Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.

Sprecher, K., R. Koscik, C. Carlsson, H. Zetterberg, K. Blennow, O. Okonkwo, M. Sager, S. Asthana, S. Johnson, R. Benca, and B. Bendlin. “Poor Sleep Is Associated With CSF Biomarkers of Amyloid Pathology in Cognitively Normal Adults.”. Neurology, Vol. 89, no. 5, 2017, pp. 445-53.

To determine the relationship between sleep quality and CSF markers of Alzheimer disease (AD) pathology in late midlife.

DOI: 10.1212/WNL.0000000000004171

PubMed: 28679595